ACON
Aclarion, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$1.89
+2.16%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.90
From 52W high−76.89%
Volume13758.00
Market cap$5.45M
P/E (TTM)—
P/S (TTM)65.0x
Div yield—
Key dataOct 19, 2026
Open
$1.90
From 52W high
−76.89%
Volume
13758.00
Market cap
$5.45M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
1.2x
P/E (TTM)
—
RSI (14)
34.3
MomentumView details →
1D Return
+2.16%
YTD Return
−57.86%
SummaryUpdated Jun 1, 2026
Aclarion, Inc. (NASDAQ:ACON) is a healthcare technology company founded in 2008 and headquartered in San Mateo, California. Originally known as Nocimed, Inc., the company changed its name to Aclarion in December 2021 and went public in April 2022. The company specializes in developing software applications for magnetic resonance spectroscopy (MRS) technology, specifically targeting the diagnosis and treatment of degenerative spinal conditions. As a relatively young public company, Aclarion operates in the emerging field of medical imaging software, focusing on providing clinicians with advanced diagnostic tools to better understand and treat chronic back pain.
Similar companies
Latest newsMore news →
Aclarion announced that revised enrollment criteria for its CLARITY clinical trial had been approved at nine of the trial’s eleven active sites.12d agoAclarion, Inc. announced that NYU Langone Health joined its CLARITY randomized clinical trial as a new clinical site, bringing enrollment to eleven sites.21d agoAclarion announced the University of Arizona College of Medicine – Phoenix as a new clinical site in its CLARITY trial, bringing the total to ten actively enrolling sites.61d ago